Diet and microbiota in inflammatory bowel disease: The gut in disharmony

World Journal of Gastroenterology

Volumn 23, Issue 12, 2017, Pages 2124-2140

  Rapozo, Davy C M ^a   Bernardazzi, Claudio ^b   De Souza, Heitor Siffert Pereira ^b,c  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

Author keywords

Crohn's disease; Diet; Epigenetics; Microbiota; Ulcerative colitis

Indexed keywords

BACTERIAL COLONIZATION; CALORIC INTAKE; DIET; DIET THERAPY; DYSBIOSIS; EATING HABIT; ENVIRONMENTAL FACTOR; EPIGENETICS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIOME; NONHUMAN; NUTRITIONAL SUPPORT; NUTRITIONAL VALUE; PATHOGENESIS; REVIEW; ANIMAL; AUTOIMMUNITY; CROHN DISEASE; DISEASE EXACERBATION; FOOD; GENETIC EPIGENESIS; HOMEOSTASIS; IMMUNOLOGY; INTESTINE; INTESTINE MUCOSA; MICROBIOLOGY; MICROFLORA; MUCOSAL IMMUNITY; PATHOLOGY;

ANIMALS; AUTOIMMUNITY; CROHN DISEASE; DIET; DISEASE PROGRESSION; DYSBIOSIS; EPIGENESIS, GENETIC; FOOD; HOMEOSTASIS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; MICROBIOTA;

EID: 85017166402     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v23.i12.2124     Document Type: Review

References (187)

1. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10: 159-169 [PMID: 20182457 DOI: 10. 1038/nri2710]
2. Råberg L, Sim D, Read AF. Disentangling genetic variation for resistance and tolerance to infectious diseases in animals. Science 2007; 318: 812-814 [PMID: 17975068 DOI: 10. 1126/ science. 1148526]
3. Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 2012; 335: 936-941 [PMID: 22363001 DOI: 10. 1126/science. 1214935]
4. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010; 28: 623-667 [PMID: 20192812 DOI: 10. 1146/annurev-immunol-030409-101330]
5. Hart AL, Hendy P. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre. Proc Nutr Soc 2014; 73: 452-456 [PMID: 25221893 DOI: 10. 1017/ S0029665114001153]
6. Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 2013; 62: 1505-1510 [PMID: 24037875 DOI: 10. 1136/gutjnl-2012-303954]
7. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009; 326: 1694-1697 [PMID: 19892944 DOI: 10. 1126/science. 1177486]
8. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 2011; 140: 1713-1719 [PMID: 21530737 DOI: 10. 1053/j. gastro. 2011. 02. 011]
9. Martin R, Nauta AJ, Ben Amor K, Knippels LM, Knol J, Garssen J. Early life: gut microbiota and immune development in infancy. Benef Microbes 2010; 1: 367-382 [PMID: 21831776 DOI: 10. 3920/BM2010. 0027]
10. Zhu B, Wang X, Li L. Human gut microbiome: the second genome of human body. Protein Cell 2010; 1: 718-725 [PMID: 21203913 DOI: 10. 1007/s13238-010-0093-z]
11. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, Dervyn R, Foerstner KU, Friss C, van de Guchte M, Guedon E, Haimet F, Huber W, van Hylckama-Vlieg J, Jamet A, Juste C, Kaci G, Knol J, Lakhdari O, Layec S, Le Roux K, Maguin E, Mérieux A, Melo Minardi R, M'rini C, Muller J, Oozeer R, Parkhill J, Renault P, Rescigno M, Sanchez N, Sunagawa S, Torrejon A, Turner K, Vandemeulebrouck G, Varela E, Winogradsky Y, Zeller G, Weissenbach J, Ehrlich SD, Bork P. Enterotypes of the human gut microbiome. Nature 2011; 473: 174-180 [PMID: 21508958 DOI: 10. 1038/nature09944]
12. Nava GM, Stappenbeck TS. Diversity of the autochthonous colonic microbiota. Gut Microbes 2011; 2: 99-104 [PMID: 21694499 DOI: 10. 4161/gmic. 2. 2. 15416]
13. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, Peterson DA, Stappenbeck TS, Hsieh CS. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011; 478: 250-254 [PMID: 21937990 DOI: 10. 1038/nature10434]
14. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-323 [PMID: 19343057 DOI: 10. 1038/nri2515]
15. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449: 819-826 [PMID: 17943118 DOI: 10. 1038/nature06246]
16. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336: 1268-1273 [PMID: 22674334 DOI: 10. 1126/science. 1223490]
17. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139: 485-498 [PMID: 19836068 DOI: 10. 1016/j. cell. 2009. 09. 033]
18. Gaboriau-Routhiau V, Rakotobe S, Lécuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De Paepe M, Brandi G, Eberl G, Snel J, Kelly D, Cerf-Bensussan N. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009; 31: 677-689 [PMID: 19833089 DOI: 10. 1016/j. immuni. 2009. 08. 020]
19. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, Littman DR, Benoist C, Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32: 815-827 [PMID: 20620945 DOI: 10. 1016/j. immuni. 2010. 06. 001]
20. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011; 108 Suppl 1: 4615-4622 [PMID: 20660719 DOI: 10. 1073/ pnas. 1000082107]
21. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, McCoy KD, Macpherson AJ. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011; 34: 794-806 [PMID: 21596591 DOI: 10. 1016/ j. immuni. 2011. 03. 021]
22. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 569-573 [PMID: 23828891 DOI: 10. 1126/science. 1241165]
23. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-119 [PMID: 17973645 DOI: 10. 1111/j. 1365-2036. 2007. 03562. x]
24. Pacheco RG, Esposito CC, Müller LC, Castelo-Branco MT, Quintella LP, Chagas VL, de Souza HS, Schanaider A. Use of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis. World J Gastroenterol 2012; 18: 4278-4287 [PMID: 22969190 DOI: 10. 3748/wjg. v18. i32. 4278]
25. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451-455 [PMID: 24226773 DOI: 10. 1038/nature12726]
26. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 2014; 111: 2247-2252 [PMID: 24390544 DOI: 10. 1073/pnas. 1322269111
27. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446-450 [PMID: 24226770 DOI: 10. 1038/nature12721]
28. Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat Immunol 2011; 12: 5-9 [PMID: 21169997 DOI: 10. 1038/ni0111-5]
29. Duffy LC, Raiten DJ, Hubbard VS, Starke-Reed P. Progress and challenges in developing metabolic footprints from diet in human gut microbial cometabolism. J Nutr 2015; 145: 1123S-1130S [PMID: 25833886 DOI: 10. 3945/jn. 114. 194936]
30. Laitinen K, Collado MC, Isolauri E. Early nutritional environment: focus on health effects of microbiota and probiotics. Benef Microbes 2010; 1: 383-390 [PMID: 21831777 DOI: 10. 3920/ BM2010. 0045]
31. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature 2011; 474: 327-336 [PMID: 21677749 DOI: 10. 1038/nature10213]
32. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258-1270 [PMID: 22424233 DOI: 10. 1016/ j. cell. 2012. 01. 035]
33. Ley RE, Hamady M, Lozupone C, Turnbaugh PJ, Ramey RR, Bircher JS, Schlegel ML, Tucker TA, Schrenzel MD, Knight R, Gordon JI. Evolution of mammals and their gut microbes. Science 2008; 320: 1647-1651 [PMID: 18497261 DOI: 10. 1126/ science. 1155725]
34. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107: 14691-14696 [PMID: 20679230 DOI: 10. 1073/pnas. 1005963107]
35. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-108 [PMID: 21885731 DOI: 10. 1126/science. 1208344]
36. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-563 [PMID: 24336217 DOI: 10. 1038/nature12820]
37. Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc 2003; 62: 67-72 [PMID: 12740060 DOI: 10. 1079/PNS2002207]
38. Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, Flint HJ. Phylogenetic relationships of butyrateproducing bacteria from the human gut. Appl Environ Microbiol 2000; 66: 1654-1661 [PMID: 10742256]
39. Hu Y, Le Leu RK, Christophersen CT, Somashekar R, Conlon MA, Meng XQ, Winter JM, Woodman RJ, McKinnon R, Young GP. Manipulation of the gut microbiota using resistant starch is associated with protection against colitis-associated colorectal cancer in rats. Carcinogenesis 2016; 37: 366-375 [PMID: 26905582 DOI: 10. 1093/carcin/bgw019]
40. Wang H, Shi P, Zuo L, Dong J, Zhao J, Liu Q, Zhu W. Dietary Non-digestible Polysaccharides Ameliorate Intestinal Epithelial Barrier Dysfunction in IL-10 Knockout Mice. J Crohns Colitis 2016; 10: 1076-1086 [PMID: 26944415 DOI: 10. 1093/ecco-jcc/ jjw065]
41. Hung TV, Suzuki T. Dietary Fermentable Fiber Reduces Intestinal Barrier Defects and Inflammation in Colitic Mice. J Nutr 2016; 146: 1970-1979 [PMID: 27605405 DOI: 10. 3945/jn. 116. 232538]
42. Calder PC. Polyunsaturated fatty acids and inflammation. Biochem Soc Trans 2005; 33: 423-427 [PMID: 15787620 DOI: 10. 1042/BST0330423]
43. Lewis JD, Abreu MT. Diet as a Trigger or Therapy for Inflammatory Bowel Diseases. Gastroenterology 2017; 152: 398-414. e6 [PMID: 27793606 DOI: 10. 1053/j. gastro. 2016. 10. 019]
44. Charlebois A, Rosenfeld G, Bressler B. The Impact of Dietary Interventions on the Symptoms of Inflammatory Bowel Disease: A Systematic Review. Crit Rev Food Sci Nutr 2016; 56: 1370-1378 [PMID: 25569442 DOI: 10. 1080/10408398. 2012. 760515]
45. Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn's disease exclusion diet is effective for induction of remission in children and young adults with Crohn's disease. Inflamm Bowel Dis 2014; 20: 1353-1360 [PMID: 24983973 DOI: 10. 1097/MIB. 0000000000000110]
46. Olendzki BC, Silverstein TD, Persuitte GM, Ma Y, Baldwin KR, Cave D. An anti-inflammatory diet as treatment for inflammatory bowel disease: A case series report. Nutr J 2014; 13: 5 [PMID: 24428901 DOI: 10. 1186/1475-2891-13-5]
47. Mayneris-Perxachs J, Bolick DT, Leng J, Medlock GL, Kolling GL, Papin JA, Swann JR, Guerrant RL. Protein-and zinc-deficient diets modulate the murine microbiome and metabolic phenotype. Am J Clin Nutr 2016; 104: 1253-1262 [PMID: 27733402 DOI: 10. 3945/ajcn. 116. 131797]
48. Virtanen SM. Dietary factors in the development of type 1 diabetes. Pediatr Diabetes 2016; 17 Suppl 22: 49-55 [PMID: 27411437 DOI: 10. 1111/pedi. 12341]
49. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136: 65-80 [PMID: 19026645 DOI: 10. 1053/j. gastro. 2008. 10. 080]
50. Kranich J, Maslowski KM, Mackay CR. Commensal flora and the regulation of inflammatory and autoimmune responses. Semin Immunol 2011; 23: 139-145 [PMID: 21292499 DOI: 10. 1016/ j. smim. 2011. 01. 011]
51. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut 2008; 57: 1185-1191 [PMID: 18515412 DOI: 10. 1136/ gut. 2007. 122143]
52. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54. e42; quiz e30 [PMID: 22001864 DOI: 10. 1053/ j. gastro. 2011. 10. 001]
53. Albenberg LG, Lewis JD, Wu GD. Food and the gut microbiota in inflammatory bowel diseases: A critical connection. Curr Opin Gastroenterol 2012; 28: 314-320 [PMID: 22573192 DOI: 10. 1097/ MOG. 0b013e328354586f]
54. Rogler G, Zeitz J, Biedermann L. The Search for Causative Environmental Factors in Inflammatory Bowel Disease. Dig Dis 2016; 34 Suppl 1: 48-55 [PMID: 27548430 DOI: 10. 1159/000447283]
55. Rook GA. Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol 2012; 42: 5-15 [PMID: 22090147 DOI: 10. 1007/ s12016-011-8285-8]
56. Saidel-Odes L, Odes S. Hygiene hypothesis in inflammatory bowel disease. Ann Gastroenterol 2014; 27: 189-190 [PMID: 24975779]
57. García Rodríguez LA, Ruigómez A, Panés J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130: 1588-1594 [PMID: 16697722 DOI: 10. 1053/j. gastro. 2006. 02. 004]
58. Hviid A, Svanström H, Frisch M. Antibiotic use and inflammatory bowel diseases in childhood. Gut 2011; 60: 49-54 [PMID: 20966024 DOI: 10. 1136/gut. 2010. 219683]
59. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474: 307-317 [PMID: 21677747 DOI: 10. 1038/nature10209]
60. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Buning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, International IBDGC, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124 [PMID: 23128233 DOI: 10. 1038/nature11582]
61. Shanahan F. Irritable bowel syndrome: shifting the focus toward the gut microbiota. Gastroenterology 2007; 133: 340-342 [PMID: 17631152 DOI: 10. 1053/j. gastro. 2007. 05. 030]
62. Swidsinski A, Loening-Baucke V, Verstraelen H, Osowska S, Doerffel Y. Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology 2008; 135: 568-579 [PMID: 18570896 DOI: 10. 1053/ j. gastro. 2008. 04. 017]
63. Quigley EM. Commensal bacteria: the link between IBS and IBD? Curr Opin Clin Nutr Metab Care 2011; 14: 497-503 [PMID: 21673572 DOI: 10. 1097/MCO. 0b013e328348c033]
64. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI, Chervonsky AV. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008; 455: 1109-1113 [PMID: 18806780 DOI: 10. 1038/nature07336]
65. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63 [PMID: 21475195 DOI: 10. 1038/ nature09922]
66. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479: 538-541 [PMID: 22031325 DOI: 10. 1038/ nature10554]
67. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594 [PMID: 18242222 DOI: 10. 1053/j. gastro. 2007. 11. 059]
68. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-791 [PMID: 9691915]
69. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, Targan SR, Fort M, Hershberg RM. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest 2004; 113: 1296-1306 [PMID: 15124021 DOI: 10. 1172/JCI20295]
70. Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006; 131: 366-378 [PMID: 16890590 DOI: 10. 1053/j. gastro. 2006. 04. 030]
71. Xiong Y, Wang GZ, Zhou JQ, Xia BQ, Wang XY, Jiang B. Serum antibodies to microbial antigens for Crohn's disease progression: A meta-analysis. Eur J Gastroenterol Hepatol 2014; 26: 733-742 [PMID: 24901819 DOI: 10. 1097/MEG. 0000000000000102]
72. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998; 114: 262-267 [PMID: 9453485]
73. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology 2013; 145: 970-977 [PMID: 23912083 DOI: 10. 1053/j. gastro. 2013. 07. 050]
74. Racine A, Carbonnel F, Chan SS, Hart AR, Bueno-de-Mesquita HB, Oldenburg B, van Schaik FD, Tjønneland A, Olsen A, Dahm CC, Key T, Luben R, Khaw KT, Riboli E, Grip O, Lindgren S, Hallmans G, Karling P, Clavel-Chapelon F, Bergman MM, Boeing H, Kaaks R, Katzke VA, Palli D, Masala G, Jantchou P, Boutron-Ruault MC. Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study. Inflamm Bowel Dis 2016; 22: 345-354 [PMID: 26717318 DOI: 10. 1097/ MIB. 0000000000000638]
75. Tjonneland A, Overvad K, Bergmann MM, Nagel G, Linseisen J, Hallmans G, Palmqvist R, Sjodin H, Hagglund G, Berglund G, Lindgren S, Grip O, Palli D, Day NE, Khaw KT, Bingham S, Riboli E, Kennedy H, Hart A. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: A nested case-control study within a European prospective cohort study. Gut 2009; 58: 1606-1611 [PMID: 19628674 DOI: 10. 1136/ gut. 2008. 169078]
76. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Willett WC, Richter JM, Chan AT. Longterm intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2014; 63: 776-784 [PMID: 23828881 DOI: 10. 1136/ gutjnl-2013-305304]
77. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. Dietary-fatinduced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 2012; 487: 104-108 [PMID: 22722865 DOI: 10. 1038/nature11225]
78. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1720-1728 [PMID: 21530738 DOI: 10. 1053/j. gastro. 2011. 01. 054]
79. Hansen R, Russell RK, Reiff C, Louis P, McIntosh F, Berry SH, Mukhopadhya I, Bisset WM, Barclay AR, Bishop J, Flynn DM, McGrogan P, Loganathan S, Mahdi G, Flint HJ, El-Omar EM, Hold GL. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis. Am J Gastroenterol 2012; 107: 1913-1922 [PMID: 23044767 DOI: 10. 1038/ajg. 2012. 335]
80. Man SM, Kaakoush NO, Mitchell HM. The role of bacteria and pattern-recognition receptors in Crohn's disease. Nat Rev Gastroenterol Hepatol 2011; 8: 152-168 [PMID: 21304476 DOI: 10. 1038/nrgastro. 2011. 3]
81. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008; 105: 16731-16736 [PMID: 18936492 DOI: 10. 1073/pnas. 0804812105]
82. Takahashi K, Nishida A, Fujimoto T, Fujii M, Shioya M, Imaeda H, Inatomi O, Bamba S, Sugimoto M, Andoh A. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease. Digestion 2016; 93: 59-65 [PMID: 26789999 DOI: 10. 1159/000441768]
83. Gevers D, Kugathasan S, Denson LA, Vázquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, González A, McDonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15: 382-392 [PMID: 24629344 DOI: 10. 1016/j. chom. 2014. 02. 005]
84. Wright EK, Kamm MA, Teo SM, Inouye M, Wagner J, Kirkwood CD. Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: A systematic review. Inflamm Bowel Dis 2015; 21: 1219-1228 [PMID: 25844959 DOI: 10. 1097/ MIB. 0000000000000382]
85. Andoh A, Imaeda H, Aomatsu T, Inatomi O, Bamba S, Sasaki M, Saito Y, Tsujikawa T, Fujiyama Y. Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol 2011; 46: 479-486 [PMID: 21253779 DOI: 10. 1007/s00535-010-0368-4]
86. Li KY, Wang JL, Wei JP, Gao SY, Zhang YY, Wang LT, Liu G. Fecal microbiota in pouchitis and ulcerative colitis. World J Gastroenterol 2016; 22: 8929-8939 [PMID: 27833384 DOI: 10. 3748/wjg. v22. i40. 8929]
87. Takeshita K, Mizuno S, Mikami Y, Sujino T, Saigusa K, Matsuoka K, Naganuma M, Sato T, Takada T, Tsuji H, Kushiro A, Nomoto K, Kanai T. A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients. Inflamm Bowel Dis 2016; 22: 2802-2810 [PMID: 27824645 DOI: 10. 1097/ MIB. 0000000000000972]
88. Rausch P, Rehman A, Künzel S, Häsler R, Ott SJ, Schreiber S, Rosenstiel P, Franke A, Baines JF. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA 2011; 108: 19030-19035 [PMID: 22068912 DOI: 10. 1073/pnas. 1106408108]
89. Rehman A, Sina C, Gavrilova O, Häsler R, Ott S, Baines JF, Schreiber S, Rosenstiel P. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011; 60: 1354-1362 [PMID: 21421666 DOI: 10. 1136/gut. 2010. 216259]
90. Wang J, Linnenbrink M, Künzel S, Fernandes R, Nadeau MJ, Rosenstiel P, Baines JF. Dietary history contributes to enterotypelike clustering and functional metagenomic content in the intestinal microbiome of wild mice. Proc Natl Acad Sci USA 2014; 111: E2703-E2710 [PMID: 24912178 DOI: 10. 1073/pnas. 1402342111]
91. Rehman A, Rausch P, Wang J, Skieceviciene J, Kiudelis G, Bhagalia K, Amarapurkar D, Kupcinskas L, Schreiber S, Rosenstiel P, Baines JF, Ott S. Geographical patterns of the standing and active human gut microbiome in health and IBD. Gut 2016; 65: 238-248 [PMID: 25567118 DOI: 10. 1136/gutjnl-2014-308341]
92. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785 [PMID: 17699621 DOI: 10. 1073/pnas. 0706625104]
93. Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al-Lazikani B, Lees W, Novelli M, Bloom S, Segal AW. Defective acute inflammation in Crohn's disease: A clinical investigation. Lancet 2006; 367: 668-678 [PMID: 16503465 DOI: 10. 1016/ S0140-6736(06)68265-2]
94. Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, Sewell GW, Palmer CD, Wilde J, Foxwell BM, Gloger IS, Sweeting T, Marsh M, Walker AP, Bloom SL, Segal AW. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 2009; 206: 1883-1897 [PMID: 19652016 DOI: 10. 1084/ jem. 20091233]
95. Sewell GW, Marks DJ, Segal AW. The immunopathogenesis of Crohn's disease: A three-stage model. Curr Opin Immunol 2009; 21: 506-513 [PMID: 19665880 DOI: 10. 1016/j. coi. 2009. 06. 003]
96. Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ, Campbell BJ, Jewell D, Simmons A. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16: 90-97 [PMID: 19966812 DOI: 10. 1038/nm. 2069]
97. Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A. Crohn's disease: NOD2, autophagy and ER stress converge. Gut 2011; 60: 1580-1588 [PMID: 21252204 DOI: 10. 1136/gut. 2009. 206466]
98. Salem M, Ammitzboell M, Nys K, Seidelin JB, Nielsen OH. ATG16L1: A multifunctional susceptibility factor in Crohn disease. Autophagy 2015; 11: 585-594 [PMID: 25906181 DOI: 10. 1080/15 548627. 2015. 1017187]
99. Kaser A, Martínez-Naves E, Blumberg RS. Endoplasmic reticulum stress: implications for inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol 2010; 26: 318-326 [PMID: 20495455 DOI: 10. 1097/MOG. 0b013e32833a9ff1]
100. Hosomi S, Kaser A, Blumberg RS. Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 2015; 31: 81-88 [PMID: 25426970 DOI: 10. 1097/MOG. 0000000000000144]
101. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H, Fellermann K, Ganz T, Stange EF, Bevins CL. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc Natl Acad Sci USA 2005; 102: 18129-18134 [PMID: 16330776 DOI: 10. 1073/pnas. 0505256102]
102. Billmann-Born S, Lipinski S, Böck J, Till A, Rosenstiel P, Schreiber S. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease. Eur J Cell Biol 2011; 90: 593-602 [PMID: 21146253 DOI: 10. 1016/ j. ejcb. 2010. 10. 015]
103. Shaw MH, Kamada N, Warner N, Kim YG, Nuñez G. The everexpanding function of NOD2: autophagy, viral recognition, and T cell activation. Trends Immunol 2011; 32: 73-79 [PMID: 21251876 DOI: 10. 1016/j. it. 2010. 12. 007]
104. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, Günther S, Prescott NJ, Onnie CM, Häsler R, Sipos B, Fölsch UR, Lengauer T, Platzer M, Mathew CG, Krawczak M, Schreiber S. A genomewide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 207-211 [PMID: 17200669 DOI: 10. 1038/ng1954]
105. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, Drummond H, Lees CW, Khawaja SA, Bagnall R, Burke DA, Todhunter CE, Ahmad T, Onnie CM, McArdle W, Strachan D, Bethel G, Bryan C, Lewis CM, Deloukas P, Forbes A, Sanderson J, Jewell DP, Satsangi J, Mansfield JC, Cardon L, Mathew CG. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007; 39: 830-832 [PMID: 17554261 DOI: 10. 1038/ng2061]
106. Hoefkens E, Nys K, John JM, Van Steen K, Arijs I, Van der Goten J, Van Assche G, Agostinis P, Rutgeerts P, Vermeire S, Cleynen I. Genetic association and functional role of Crohn disease risk alleles involved in microbial sensing, autophagy, and endoplasmic reticulum (ER) stress. Autophagy 2013; 9: 2046-2055 [PMID: 24247223 DOI: 10. 4161/auto. 26337]
107. Elinav E, Strowig T, Henao-Mejia J, Flavell RA. Regulation of the antimicrobial response by NLR proteins. Immunity 2011; 34: 665-679 [PMID: 21616436 DOI: 10. 1016/j. immuni. 2011. 05. 007]
108. Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, Punit S, Karlsson M, Bry L, Glickman JN, Gordon JI, Onderdonk AB, Glimcher LH. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010; 8: 292-300 [PMID: 20833380 DOI: 10. 1016/j. chom. 2010. 08. 004]
109. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010; 107: 11971-11975 [PMID: 20566857 DOI: 10. 1073/pnas. 1002601107]
110. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT, Ley RE. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011; 108 Suppl 1: 4578-4585 [PMID: 20668239 DOI: 10. 1073/ pnas. 1000081107]
111. Hanson LA. Session 1: Feeding and infant development breastfeeding and immune function. Proc Nutr Soc 2007; 66: 384-396 [PMID: 17637091 DOI: 10. 1017/S0029665107005654]
112. Barclay AR, Russell RK, Wilson ML, Gilmour WH, Satsangi J, Wilson DC. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr 2009; 155: 421-426 [PMID: 19464699 DOI: 10. 1016/ j. jpeds. 2009. 03. 017]
113. Nickerson KP, McDonald C. Crohn's disease-associated adherentinvasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin. PLoS One 2012; 7: e52132 [PMID: 23251695 DOI: 10. 1371/journal. pone. 0052132]
114. Chabra S, Arnold JD, Leslie GI, Bowen JR, Earl J, Wood F. Vitamin A status in preterm neonates with and without chronic lung disease. J Paediatr Child Health 1994; 30: 432-435 [PMID: 7833081]
115. Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling HJ, Langa F, Di Santo JP, Eberl G. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010; 330: 665-669 [PMID: 20929731 DOI: 10. 1126/science. 1194597]
116. Werner T, Wagner SJ, Martínez I, Walter J, Chang JS, Clavel T, Kisling S, Schuemann K, Haller D. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 2011; 60: 325-333 [PMID: 21076126 DOI: 10. 1136/ gut. 2010. 216929]
117. Adorini L, Penna G. Dendritic cell tolerogenicity: A key mechanism in immunomodulation by vitamin D receptor agonists. Hum Immunol 2009; 70: 345-352 [PMID: 19405173]
118. Nerich V, Jantchou P, Boutron-Ruault MC, Monnet E, Weill A, Vanbockstael V, Auleley GR, Balaire C, Dubost P, Rican S, Allemand H, Carbonnel F. Low exposure to sunlight is a risk factor for Crohn's disease. Aliment Pharmacol Ther 2011; 33: 940-945 [PMID: 21332762 DOI: 10. 1111/j. 1365-2036. 2011. 04601. x]
119. Jørgensen SP, Hvas CL, Agnholt J, Christensen LA, Heickendorff L, Dahlerup JF. Active Crohn's disease is associated with low vitamin D levels. J Crohns Colitis 2013; 7: e407-e413 [PMID: 23403039 DOI: 10. 1016/j. crohns. 2013. 01. 012]
120. Limketkai BN, Bayless TM, Brant SR, Hutfless SM. Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther 2014; 40: 508-517 [PMID: 24943863 DOI: 10. 1111/apt. 12845]
121. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13: 484-492 [PMID: 22641018 DOI: 10. 1038/nrg3230]
122. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011; 25: 1010-1022 [PMID: 21576262 DOI: 10. 1101/gad. 2037511]
123. Benchimol EI, Mack DR, Guttmann A, Nguyen GC, To T, Mojaverian N, Quach P, Manuel DG. Inflammatory bowel disease in immigrants to Canada and their children: A population-based cohort study. Am J Gastroenterol 2015; 110: 553-563 [PMID: 25756238 DOI: 10. 1038/ajg. 2015. 52]
124. Kellermayer R. Epigenetics and the developmental origins of inflammatory bowel diseases. Can J Gastroenterol 2012; 26: 909-915 [PMID: 23248794]
125. Koukos G, Polytarchou C, Kaplan JL, Oikonomopoulos A, Ziring D, Hommes DW, Wahed R, Kokkotou E, Pothoulakis C, Winter HS, Iliopoulos D. A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium. Inflamm Bowel Dis 2015; 21: 996-1005 [PMID: 25738378 DOI: 10. 1097/MIB. 0000000000000339]
126. Scarpa M, Stylianou E. Epigenetics: Concepts and relevance to IBD pathogenesis. Inflamm Bowel Dis 2012; 18: 1982-1996 [PMID: 22407855 DOI: 10. 1002/ibd. 22934]
127. Barnett M, Bermingham E, McNabb W, Bassett S, Armstrong K, Rounce J, Roy N. Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease. Mutat Res 2010; 690: 71-80 [PMID: 20188748 DOI: 10. 1016/ j. mrfmmm. 2010. 02. 006]
128. Kraiczy J, Nayak K, Ross A, Raine T, Mak TN, Gasparetto M, Cario E, Rakyan V, Heuschkel R, Zilbauer M. Assessing DNA methylation in the developing human intestinal epithelium: potential link to inflammatory bowel disease. Mucosal Immunol 2016; 9: 647-658 [PMID: 26376367 DOI: 10. 1038/mi. 2015. 88]
129. Harris RA, Shah R, Hollister EB, Tronstad RR, Hovdenak N, Szigeti R, Versalovic J, Kellermayer R. Colonic Mucosal Epigenome and Microbiome Development in Children and Adolescents. J Immunol Res 2016; 2016: 9170162 [PMID: 27006956 DOI: 10. 1155/2016/9170162]
130. Gallou-Kabani C, Vigé A, Gross MS, Junien C. Nutriepigenomics: lifelong remodelling of our epigenomes by nutritional and metabolic factors and beyond. Clin Chem Lab Med 2007; 45: 321-327 [PMID: 17378726 DOI: 10. 1515/CCLM. 2007. 081]
131. Davis CD, Uthus EO. DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 2004; 229: 988-995 [PMID: 15522834]
132. Garfinkel MD, Ruden DM. Chromatin effects in nutrition, cancer, and obesity. Nutrition 2004; 20: 56-62 [PMID: 14698015]
133. Al-Awadi FM, Khan I, Dashti HM, Srikumar TS. Colitis-induced changes in the level of trace elements in rat colon and other tissues. Ann Nutr Metab 1998; 42: 304-310 [PMID: 9812022]
134. Wani NA, Hamid A, Kaur J. Folate status in various pathophysiological conditions. IUBMB Life 2008; 60: 834-842 [PMID: 18942083 DOI: 10. 1002/iub. 133]
135. McKay JA, Williams EA, Mathers JC. Gender-specific modulation of tumorigenesis by folic acid supply in the Apc mouse during early neonatal life. Br J Nutr 2008; 99: 550-558 [PMID: 17868491 DOI: 10. 1017/S0007114507819131]
136. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 2009; 1: 239-259 [PMID: 20495664 DOI: 10. 2217/epi. 09. 33]
137. Lu Q, Qiu X, Hu N, Wen H, Su Y, Richardson BC. Epigenetics, disease, and therapeutic interventions. Ageing Res Rev 2006; 5: 449-467 [PMID: 16965942 DOI: 10. 1016/j. arr. 2006. 07. 001]
138. Davis CD, Uthus EO. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J Nutr 2003; 133: 2907-2914 [PMID: 12949386]
139. Choi SW, Friso S, Keyes MK, Mason JB. Folate supplementation increases genomic DNA methylation in the liver of elder rats. Br J Nutr 2005; 93: 31-35 [PMID: 15705222]
140. Arasaradnam RP, Commane DM, Bradburn D, Mathers JC. A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 2008; 3: 193-198 [PMID: 18682688]
141. Chapkin RS, Kamen BA, Callaway ES, Davidson LA, George NI, Wang N, Lupton JR, Finnell RH. Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer. J Nutr Biochem 2009; 20: 649-655 [PMID: 18926688 DOI: 10. 1016/j. jnutbio. 2008. 07. 001]
142. Qin T, Du M, Du H, Shu Y, Wang M, Zhu L. Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials. Sci Rep 2015; 5: 12044 [PMID: 26131763 DOI: 10. 1038/srep12044]
143. Tio M, Andrici J, Cox MR, Eslick GD. Folate intake and the risk of upper gastrointestinal cancers: A systematic review and metaanalysis. J Gastroenterol Hepatol 2014; 29: 250-258 [PMID: 24224911 DOI: 10. 1111/jgh. 12446]
144. MacFarlane AJ, Behan NA, Matias FM, Green J, Caldwell D, Brooks SP. Dietary folate does not significantly affect the intestinal microbiome, inflammation or tumorigenesis in azoxymethanedextran sodium sulphate-treated mice. Br J Nutr 2013; 109: 630-638 [PMID: 23021249 DOI: 10. 1017/S0007114512001857]
145. Davis CD, Uthus EO, Finley JW. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr 2000; 130: 2903-2909 [PMID: 11110844]
146. Davis CD, Uthus EO. Dietary selenite and azadeoxycytidine treatments affect dimethylhydrazine-induced aberrant crypt formation in rat colon and DNA methylation in HT-29 cells. J Nutr 2002; 132: 292-297 [PMID: 11823593]
147. Tirosh O, Levy E, Reifen R. High selenium diet protects against TNBS-induced acute inflammation, mitochondrial dysfunction, and secondary necrosis in rat colon. Nutrition 2007; 23: 878-886[PMID: 17936198 DOI: 10. 1016/j. nut. 2007. 08. 019]
148. Barrett CW, Singh K, Motley AK, Lintel MK, Matafonova E, Bradley AM, Ning W, Poindexter SV, Parang B, Reddy VK, Chaturvedi R, Fingleton BM, Washington MK, Wilson KT, Davies SS, Hill KE, Burk RF, Williams CS. Dietary selenium deficiency exacerbates DSS-induced epithelial injury and AOM/DSS-induced tumorigenesis. PLoS One 2013; 8: e67845 [PMID: 23861820 DOI: 10. 1371/journal. pone. 0067845]
149. Castro Aguilar-Tablada T, Navarro-Alarcón M, Quesada Granados J, Samaniego Sánchez C, Rufián-Henares JÁ, Nogueras-Lopez F. Ulcerative Colitis and Crohn's Disease Are Associated with Decreased Serum Selenium Concentrations and Increased Cardiovascular Risk. Nutrients 2016; 8: [PMID: 27916926 DOI: 10. 3390/nu8120780]
150. Richman E, Rhodes JM. Review article: evidence-based dietary advice for patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38: 1156-1171 [PMID: 24102340 DOI: 10. 1111/apt. 12500]
151. O'Hara AM, Shanahan F. Gut microbiota: mining for therapeutic potential. Clin Gastroenterol Hepatol 2007; 5: 274-284 [PMID: 17368226 DOI: 10. 1016/j. cgh. 2006. 12. 009]
152. Sartor RB, Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep 2007; 9: 497-507 [PMID: 18377803]
153. Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr Pharm Des 2009; 15: 1528-1536 [PMID: 19442170]
154. Mach T. Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol 2006; 57 Suppl 9: 23-33 [PMID: 17242485]
155. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M, Kamm MA. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004; 53: 108-114 [PMID: 14684584]
156. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126: 1620-1633 [PMID: 15168372]
157. Ewaschuk JB, Dieleman LA. Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol 2006; 12: 5941-5950 [PMID: 17009391 DOI: 10. 3748/wjg. v12. i37. 5941]
158. Mack DR. Probiotics in inflammatory bowel diseases and associated conditions. Nutrients 2011; 3: 245-264 [PMID: 22254095 DOI: 10. 3390/nu3020245]
159. Sokol H. Probiotics and antibiotics in IBD. Dig Dis 2014; 32 Suppl 1: 10-17 [PMID: 25531348 DOI: 10. 1159/000367820]
160. Guslandi M. Role of Probiotics in Crohn's Disease and in Pouchitis. J Clin Gastroenterol 2015; 49 Suppl 1: S46-S49 [PMID: 26447964 DOI: 10. 1097/MCG. 0000000000000351]
161. Fedorak RN, Feagan BG, Hotte N, Leddin D, Dieleman LA, Petrunia DM, Enns R, Bitton A, Chiba N, Paré P, Rostom A, Marshall J, Depew W, Bernstein CN, Panaccione R, Aumais G, Steinhart AH, Cockeram A, Bailey RJ, Gionchetti P, Wong C, Madsen K. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease. Clin Gastroenterol Hepatol 2015; 13: 928-935. e2 [PMID: 25460016 DOI: 10. 1016/j. cgh. 2014. 10. 031]
162. Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G, Gaetani E, Sgambato A, Gasbarrini A. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int 2013; 2013: 435268 [PMID: 23991417 DOI: 10. 1155/2013/435268]
163. Fujimori S, Tatsuguchi A, Gudis K, Kishida T, Mitsui K, Ehara A, Kobayashi T, Sekita Y, Seo T, Sakamoto C. High dose probiotic and prebiotic cotherapy for remission induction of active Crohn' s disease. J Gastroenterol Hepatol 2007; 22: 1199-1204 [PMID: 17688660 DOI: 10. 1111/j. 1440-1746. 2006. 04535. x]
164. Chandler M, Wollins E, Toles A, Borum M, Doman DB. The emerging therapeutic role of probiotics in inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2008; 4: 634-640 [PMID: 22798747]
165. Khoruts A, Sadowsky MJ. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol 2011; 4: 4-7 [PMID: 21150894 DOI: 10. 1038/mi. 2010. 79]
166. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A, Louie T, Martinelli LP, Moore TA, Russell G, Surawicz C. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044-1049 [PMID: 21871249 DOI: 10. 1016/j. cgh. 2011. 08. 014]
167. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012; 36: 503-516 [PMID: 22827693 DOI: 10. 1111/j. 1365-2036. 2012. 05220. x]
168. Colman RJ, Rubin DT. Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and metaanalysis. J Crohns Colitis 2014; 8: 1569-1581 [PMID: 25223604 DOI: 10. 1016/j. crohns. 2014. 08. 006]
169. Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 2015; 30: 51-58 [PMID: 25168749 DOI: 10. 1111/ jgh. 12727]
170. Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, Xu H, Xiang J, He Z, Zhang T, Nie Y, Wu K, Fan D, Ji G, Zhang F. Step-up fecal microbiota transplantation strategy: A pilot study for steroiddependent ulcerative colitis. J Transl Med 2015; 13: 298 [PMID: 26363929 DOI: 10. 1186/s12967-015-0646-2]
171. Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C, Armstrong D, Marshall JK, Kassam Z, Reinisch W, Lee CH. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology 2015; 149: 102-109. e6 [PMID: 25857665 DOI: 10. 1053/j. gastro. 2015. 04. 001]
172. Lee HS. Impact of Maternal Diet on the Epigenome during In Utero Life and the Developmental Programming of Diseases in Childhood and Adulthood. Nutrients 2015; 7: 9492-9507 [PMID: 26593940 DOI: 10. 3390/nu7115467]
173. Attig L, Gabory A, Junien C. Nutritional developmental epigenomics: immediate and long-lasting effects. Proc Nutr Soc 2010; 69: 221-231 [PMID: 20202279 DOI: 10. 1017/ S002966511000008X]
174. MacLennan NK, James SJ, Melnyk S, Piroozi A, Jernigan S, Hsu JL, Janke SM, Pham TD, Lane RH. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics 2004; 18: 43-50 [PMID: 15084713 DOI: 10. 1152/physiolgenomics. 00042. 2004]
175. Vanhees K, Vonhögen IG, van Schooten FJ, Godschalk RW. You are what you eat, and so are your children: the impact of micronutrients on the epigenetic programming of offspring. Cell Mol Life Sci 2014; 71: 271-285 [PMID: 23892892 DOI: 10. 1007/ s00018-013-1427-9]
176. Vickers MH. Early life nutrition, epigenetics and programming of later life disease. Nutrients 2014; 6: 2165-2178 [PMID: 24892374 DOI: 10. 3390/nu6062165]
177. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR, Welfare MR. Influence of dietary factors on the clinical course of ulcerative colitis: A prospective cohort study. Gut 2004; 53: 1479-1484 [PMID: 15361498 DOI: 10. 1136/gut. 2003. 024828]
178. Magee EA, Edmond LM, Tasker SM, Kong SC, Curno R, Cummings JH. Associations between diet and disease activity in ulcerative colitis patients using a novel method of data analysis. Nutr J 2005; 4: 7 [PMID: 15705205 DOI: 10. 1186/1475-2891-4-7]
179. Guerreiro CS, Ferreira P, Tavares L, Santos PM, Neves M, Brito M, Cravo M. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease. Am J Gastroenterol 2009; 104: 2241-2249 [PMID: 19550417 DOI: 10. 1038/ ajg. 2009. 313]
180. Ferreira P, Cravo M, Guerreiro CS, Tavares L, Santos PM, Brito M. Fat intake interacts with polymorphisms of Caspase9, FasLigand and PPARgamma apoptotic genes in modulating Crohn's disease activity. Clin Nutr 2010; 29: 819-823 [PMID: 20650551 DOI: 10. 1016/j. clnu. 2010. 06. 008]
181. Takada T, Kurakawa T, Tsuji H, Nomoto K. Fusicatenibacter saccharivorans gen. nov., sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 2013; 63: 3691-3696 [PMID: 23625266 DOI: 10. 1099/ijs. 0. 045823-0]
182. Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol 2013; 16: 255-261 [PMID: 23831042 DOI: 10. 1016/j. mib. 2013. 06. 003]
183. Park SK, Kim MS, Bae JW. Blautia faecis sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 2013; 63: 599-603 [PMID: 22544782 DOI: 10. 1099/ijs. 0. 036541-0]
184. Swidsinski A, Loening-Baucke V, Herber A. Mucosal flora in Crohn's disease and ulcerative colitis-an overview. J Physiol Pharmacol 2009; 60 Suppl 6: 61-71 [PMID: 20224153]
185. Auchtung TA, Holder ME, Gesell JR, Ajami NJ, Duarte RT, Itoh K, Caspi RR, Petrosino JF, Horai R, Zárate-Bladés CR. Complete Genome Sequence of Turicibacter sp. Strain H121, Isolated from the Feces of a Contaminated Germ-Free Mouse. Genome Announc 2016; 4: [PMID: 27013036 DOI: 10. 1128/genomeA. 00114-16]
186. Huys G, Cnockaert M, Janda JM, Swings J. Escherichia albertii sp. nov., a diarrhoeagenic species isolated from stool specimens of Bangladeshi children. Int J Syst Evol Microbiol 2003; 53: 807-810 [PMID: 12807204 DOI: 10. 1099/ijs. 0. 02475-0]
187. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteriafermented milk on ulcerative colitis. J Am Coll Nutr 2003; 22: 56-63 [PMID: 12569115]